Article PDF
References
ORIGINAL RESEARCH PAPERS
Kohrt, H. E. et al. Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer. J. Clin. Invest. February 13, 2012 (doi: 10.1172/JCI61226)
FURTHER READING
Vanneman, M. & Dranoff, G. Combining immunotherapy and targeted therapies in cancer treatment. Nature Rev. Cancer 12, 237-251 10.1038/nrc3237 (2011)
“Sources of Nitrogen Compounds in the United States.” By Dr. C. G. Gilbert . (Smithsonian Institution, Washington, 1916.)
Related links
Rights and permissions
About this article
Cite this article
Combinations that work. Nat Rev Cancer 12, 231 (2012). https://doi.org/10.1038/nrc3250
Issue Date:
DOI: https://doi.org/10.1038/nrc3250
This article is cited by
-
Oncolytic Viruses in the Treatment of Cancer: A Review of Current Strategies
Pathology & Oncology Research (2012)
-
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
Breast Cancer Research and Treatment (2012)